European Healthtech startup funding raised during H2 2024.
In H2 2024, 199 European Healthtech companies raised a combined €2.9B across 201 funding rounds, down 36.5% versus H2 2023. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Cimeio Therapeutics | Other | Dec 2024 | €282M |
| ŌURA | Series D+ | Dec 2024 | €192M |
| Flo Health | Series C | Jul 2024 | €185M |
| Caresyntax | Series C | Aug 2024 |
11 exits · €50M disclosed.
| Lamidey Noury Medical | Acquisition | Nov 2024 | €50M |
| €164M |
| Citryll | Series B | Dec 2024 | €85M |
| Agomab Therapeutics | Series D+ | Oct 2024 | €83M |
| Antag Therapeutics | Series A | Dec 2024 | €80M |
| Huma | Series D+ | Jul 2024 | €73M |
| ŌURA | Series D+ | Nov 2024 | €71M |
| Cradle | Series B | Nov 2024 | €69M |
| Nuclera | Series A | Oct 2024 | €69M |
| Neo Medical | Other | Sep 2024 | €61M |
| Oxford Nanopore Technologies | Other | Aug 2024 | €59M |
| Quanta Dialysis Technologies | Series D+ | Nov 2024 | €57M |
| Basecamp Research | Series B | Oct 2024 | €55M |
